Your browser doesn't support javascript.
loading
Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials / 中国骨伤
China Journal of Orthopaedics and Traumatology ; (12): 609-614, 2014.
Article Dans Chinois | WPRIM | ID: wpr-249306
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the clinical efficiency of selective cyclo-oxygenase-2 (COX-2) inhibitor compared to traditional nonselective NSAIDs for the prevention of heterotopic ossification (HO) after total hip arthroplasty (THA).</p><p><b>METHODS</b>By searching Medline, Embase, CENTRAL (Cochrane Central Register of Controlled Trials) and Science Citation Index et al, only randomised controlled studies of selective COX-2 inhibitors VS nonselective COX-1 and COX-2 inhibitors for the prevention of HO after THA were included. The quality assessment of included studies was evaluated according to the standard of the Cochrane Collaboration, and the data were analysised by statistic software Stata 10.0. The HO incidence of both groups in different degrees was compared.</p><p><b>RESULTS</b>Four eligible randomised controlled trials of totally 808 patients were included. Meta-analysis results showed that no statistically significant difference was found in overall incidence of HO (RR = 1.08, 95% CI 0.71-1.64,P = 0.73), incidence of moderate severe HO (Brooker II and III) (RR = 0.83, 95% CI 0.48-1.42, P = 0.49) and any grade of Brooker classification between two groups. In all included studies, 16 patients receiving nonselective COX inhibitor (4.4%) discontinued treatment because of gastrointestinal toxicity,whereas 10 patients in the selective COX-2 inhibitor group (2.7%) discontinued for gastrointestinal side effects.</p><p><b>CONCLUSION</b>The selective COX-2 inhibitors are as equally effective as nonselective NSAIDs for the prevention of HO after THA. Considering the side effects of nonselective NSAIDs, selective COX-2 inhibitors were recommend for the prevention of HO after THA.</p>
Sujets)
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Essais contrôlés randomisés comme sujet / Anti-inflammatoires non stéroïdiens / Inhibiteurs des cyclooxygénases / Ossification hétérotopique / Arthroplastie prothétique de hanche / Utilisations thérapeutiques / Inhibiteurs de la cyclooxygénase 2 Type d'étude: Essai clinique contrôlé / Revues systématiques évaluées Limites du sujet: Humains langue: Chinois Texte intégral: China Journal of Orthopaedics and Traumatology Année: 2014 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Essais contrôlés randomisés comme sujet / Anti-inflammatoires non stéroïdiens / Inhibiteurs des cyclooxygénases / Ossification hétérotopique / Arthroplastie prothétique de hanche / Utilisations thérapeutiques / Inhibiteurs de la cyclooxygénase 2 Type d'étude: Essai clinique contrôlé / Revues systématiques évaluées Limites du sujet: Humains langue: Chinois Texte intégral: China Journal of Orthopaedics and Traumatology Année: 2014 Type: Article